Related Experiment Videos
T-cell lymphoma after heart transplantation
1Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Lower Saxony, Federal Republic of Germany.
American Journal of Clinical Pathology
|July 1, 1990
Summary
This case study details a T-cell lymphoma in a heart transplant recipient, highlighting a rare complication of immunosuppression. It underscores the importance of monitoring for post-transplant lymphoproliferative disorders.
Area of Science:
- Immunology
- Oncology
- Transplantation Medicine
Background:
- Orthotopic heart transplantation for dilative cardiomyopathy necessitates immunosuppression to prevent rejection.
- Immunosuppressive regimens commonly include cyclosporine A, azathioprine, and prednisolone.
- Post-transplant lymphoproliferative disorders (PTLD) are a known risk associated with long-term immunosuppression.
Observation:
- A 26-year-old female heart transplant recipient developed a high-grade malignant pleomorphic medium-size cell non-Hodgkin's lymphoma.
- The lymphoma was diagnosed via fine-needle aspiration of the liver prior to the patient's death.
- The patient experienced frequent acute rejection episodes, treated with methylprednisolone and anti-thymocyte globulin (ATG).
Findings:
- Autopsy confirmed the liver as the sole extranodal site of the T-cell lymphoma.
- Immunohistologic analysis identified the lymphomatous neoplasia as a T-cell lymphoma.
- The patient ultimately died from cardiogenic shock due to severe acute rejection.
Implications:
- This represents the third documented case of T-cell lymphoma post-organ grafting and the first in a cardiac allograft recipient.
- The case emphasizes the critical need for vigilance regarding PTLD, particularly T-cell lymphomas, in immunosuppressed transplant patients.
- Further research into the pathogenesis and early detection of PTLD in organ transplant recipients is warranted.